The importance of early genetic screening in VEO-IBD children to allow assessment before full manifestation of complications, or need for surgery9,13, was highlighted by the lethal outcome for the patient with SH2D1A deficiency (XLP1, p.R75X) while WES was being undertaken in this patient. The gene discussed is SH2D1A; the disease is inflammatory bowel disease.